Company

Dyne Therapeutics Inc DYN

Tracked across 3 disclosed holders on Protégé.

Held by these investors

Investor% of portfolioValue
Samlyn Capital0.6%$39.0M
Orbis Investment Management0.5%$155.6M
Baker Brothers Investments0.1%$18.1M

Open the full company deep-dive →